Table 1.
Change in rates of liver transplant waitlist registration over time by gender
| Etiology | Males 2016 v 2004 | Males 2016 v 2015 | Females 2016 v 2004 | Females 2016 v 2015 | ||||
|---|---|---|---|---|---|---|---|---|
|
|
|
|
|
|||||
| Change | p-value | Change | p-value | Change | p-value | Change | p-value | |
| HCV | −67% | <0.0001 | −22% | <0.0001 | −68% | <0.0001 | −27% | <0.0001 |
| ALD | 49% | <0.0001 | 10% | 0.0957 | 87% | <0.0001 | 15% | 0.0564 |
| NASH | 114% | <0.0001 | 12% | 0.0991 | 80% | <0.0001 | 9% | 0.2061 |
| HCC & HCV | 171% | <0.0001 | −12% | 0.0139 | 233% | <0.0001 | −11% | 0.1576 |
| HCV&ALD | −61% | <0.0001 | −12% | 0.0932 | −43% | 0.0103 | −15% | 0.2266 |
| HCC & NASH | 1172% | <0.0001 | 29% | 0.0203 | 2383% | <0.0001 | −11% | 0.3322 |
| HCC & ALD | 273% | <0.0001 | 11% | 0.3195 | n/a | <0.0001 | 5% | 0.8819 |
Percent change computed from observed counts over time and p-values computed from multinomial regression analysis within each sex; n/a indicates percent change not computed due to zero observations in divisor
HCV Hepatitis C virus, ALD Alcoholic liver disease, NASH Non-alcoholic steatohepatitis, HCC Hepatocellular carcinoma